Abstract
Poly(amino acid)s have received considerable attention for biomedical applications. Poly(γ-glutamic acid) (γ-PGA), a natural polymer, is synthesized by several gram-positive bacteria. γ-PGA is anionic, water soluble, biodegradable, edible, nontoxic, and nonimmunogenic for humans and the environment, and its α-carboxylate side chains can be chemically modified to introduce various drugs, or to modulate the amphiphilicity of the polymer. These features of γ-PGA are very useful for pharmaceutical and biomedical applications. This paper reviews the preparation of polymeric drugs, nanoparticles, and hydrogels composed of γ-PGA and their medical applications as drug carriers and tissue-engineering materials. γ-PGA–drug conjugates, nanoparticles, and hydrogels fabricated from γ-PGA or its derivatives have wide application for drug delivery system and regenerative medical technique.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akagi T, Higashi M, Kaneko T, Kida T, Akashi M (2005a) In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(γ-glutamic acid). Macromol Biosci 5:598–602
Akagi T, Kaneko T, Kida T, Akashi M (2005b) Preparation and characterization of biodegradable nanoparticles based on poly(γ-glutamic acid) with L-phenylalanine as a protein carrier. J Control Release 108:226–236
Akagi T, Higashi M, Kaneko T, Kida T, Akashi M (2006a) Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(γ-glutamic acid)-graft-L-phenylalanine copolymer. Biomacromolecules 7:297–303
Akagi T, Kaneko T, Kida T, Akashi M (2006b) Multifunctional conjugation of proteins on/into core-shell type nanoparticles prepared by amphiphilic poly(γ-glutamic acid). J Biomater Sci Polym Ed 17:875–892
Akagi T, Baba M, Akashi M (2007a) Preparation of nanoparticles by the self-organization of polymers consisting of hydrophobic and hydrophilic segments: potential applications. Polymer 48:6729–6747
Akagi T, Wang X, Uto T, Baba M, Akashi M (2007b) Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. Biomaterials 28:3427–3436
Akiyoshi K, Ueminami A, Kurumada S, Nomura Y (2000) Self-association of cholesteryl-bearing poly(L-lysine) in water and control of its secondary structure by host−guest interaction with cyclodextrin. Macromolecules 33:6752–6756
Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818–1822
Arimura H, Ohya Y, Ouchi T (2005) Formation of core-shell type biodegradable polymeric micelles from amphiphilic poly(aspartic acid)-block-polylactide diblock copolymer. Biomacromolecules 6:720–725
Asano T, Anai M, Sakoda H, Fujishiro M, Ono H, Kurihara H, Uchijima Y (2004) SGLT as a therapeutic target. Drugs Future 29:461–466
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252
Bodnar M, Kjoniksen AL, Molnar RM, Hartmann JF, Daroczi L, Nystrom B, Borbely J (2008) Nanoparticles formed by complexation of poly-γ-glutamic acid with lead ions. J Hazard Mater 153:1185–1192
Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R (1991) Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res 8:713–720
Damg C, Michel C, Aprahamian M, Couvreur P, Devissagnet JP (1990) Nanocapsules as carriers for oral peptide delivery. J Cantrol Release 13:233–239
Deuber HJ, Schultz W (1991) Reduced lipid concentration during four years of dialysis with low molecular weight heparin. Kidney Int 40:496–500
Di Paolo A, Danesi R, Falcone A, Cionini L, Vannozzi F, Masi G, Allegrini G, Mini E, Bocci G, Conte PF, Del Tacca M (2001) Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients. Ann Oncol 12:1301–1306
Dou H, Jiang M, Peng H, Chen D, Hong Y (2003) pH-dependent self-assembly: micellization and micelle-hollow-sphere transition of cellulose-based copolymers. Angew Chem Int Ed 42:1516–1519
Edlund U, Albertsson AC (2000) Degradable polymer microspheres for controlled drug delivery. Adv Polym Sci 157:67–112
Elamanchili P, Diwan M, Cao M, Samuel J (2004) Characterization of poly(D, L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 22:2406–2412
Fahama S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC (1996) Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116–1120
Fallon RJ, Schwartz AL (1989) Receptor-mediated delivery of drugs to hepatocytes. Adv Drug Deliv Rev 4:49–63
Gamvrellis A, Leong D, Hanley JC, Xiang SD, Mottram P, Plebanski M (2004) Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol 82:506–516
Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC (2005) Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 109:169–188
Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600–1603
Hajdu I, Bodnar M, Filipcsei G, Hartmann JF, Daroczi L, Zrinyi M, Borbely J (2009) Nanoparticles prepared by self-assembly of chitosan and poly-γ-glutamic acid. Colloid Polym Sci 286:343–350
Hans ML, Lowman AM (2002) Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 6:319–327
Harding CV, Song R (1994) Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 153:4925–4933
Hartig SM, Greene RR, DasGupta J, Carlesso G, Dikov MM, Prokop A, Davidson JM (2007) Multifunctional nanoparticulate polyelectrolyte complexes. Pharm Res 24:2353–2369
Holowka EP, Pochan DJ, Deming TJ (2005) Charged polypeptide vesicles with controllable diameter. J Am Chem Soc 127:12423–12428
Holowka EP, Sun VZ, Kamei DT, Deming TJ (2007) Polyarginine segments in block copolypeptides drive both vesicular assembly and intracellular delivery. Nat Mater 6:52–57
Hsieh CY, Tsai SP, Wang DM, Chang YN, Hsieh HJ (2005) Preparation of γ-PGA/chitosan composite tissue engineering matrices. Biomaterials 26:5617–5623
Hubbell JA (2003) Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol 14:551–558
Ikumi Y, Kida T, Sakuma S, Yamashita S, Akashi M (2008) Polymer-phloridzin conjugates as an anti-diabetic drug that inhibits glucose absorption through the Na+/glucose cotransporter (SGLT1) in the small intestine. J Control Release 125:42–49
Jaturanpinyo M, Harada A, Yuan X, Kataoka K (2004) Preparation of bionanoreactor based on core-shell structured polyion complex micelles entrapping trypsin in the core cross-linked with glutaraldehyde. Bioconjugate Chem 15:344–348
Jelinkova M, Strohalm J, Plocova D, Subr V, Stcastny M, Ulbrich K, Rihova B (1998) Targeting of human and mouse T-lymphoctes by monoclonal antibody-HPMA copolymer-doxorubicin conjugates directed against different T-cell surface antigens. J Control Release 52:253–270
Jeong JH, Kang HS, Yang SR, Kim JD (2003) Polymer micelle-like aggregates of novel amphiphilic biodegradable poly(asparagine) grafted with poly(caprolactone). Polymer 44:583–591
Jilek S, Merkle HP, Walter E (2007) DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev 57:377–390
Jin Y, Li J, Rong LF, Lu XW, Huang Y, Xu SY (2005) Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice. Acta Pharmacol Sin 26:250–256
Joyce J, Cook J, Chabot D, Hepler R, Shoop W, Xu Q, Stambaugh T, Aste-Amezaga M, Wang S, Indrawati L, Bruner M, Friedlander A, Keller P, Caulfield M (2006) Immunogenicity and protective efficacy of Bacillus anthracis poly-γ-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy. J Biol Chem 281:4831–4843
Kakizawa Y, Kataoka K (2002) Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev 54:203–222
Kaneko T, Higashi M, Matsusaki M, Akagi T, Akashi M (2005) Self-assembled soft nanofibrils of amphipathic polypeptides and their morphological transformation. Chem Mater 17:2484–2486
Kang N, Perron ME, Prudhomme RE, Zhang Y, Gaucher G, Leroux JC (2005) Stereocomplex block copolymer micelles: core-shell nanostructures with enhanced stability. Nano Lett 5:315–319
Kang HS, Park SH, Lee YG, Son I (2007) Polyelectrolyte complex hydrogel composed of chitosan and poly(γ-glutamic acid) for biological application: preparation, physical properties, and cytocompatibility. J Appl Polym Sci 103:386–394
Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kwon GS (2000) Doxorubicin-loaded poly(ethylene glycol)-poly(β-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control Release 64:143–153
Keller KM, Brauer PR, Keller JM (1989) Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate. Biochemistry 28:8100–8107
Kelton JC (1986) Heparin-induced thrombocyopenia. Haemostasis 16:173–186
Kim TW, Lee TY, Bae HC, Hahm JH, Kim YH, Park C, Kang TH, Kim CJ, Sung MH, Poo H (2007) Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity. J Immunol 179:775–780
Kim H, Akagi T, Akashi M (2009) Preparation of size tunable amphiphilic poly(amino acid) nanoparticles. Macromol Biosci 9:842–848
King EC, Watkins WJ, Blacker AJ, Bugg TDH (1998) Covalent modification in aqueous solution of poly-γ-D-glutamic acid from Bacillus licheniformis. J Polym Sci A Polym Chem 36:1995–1999
Kishida A, Goto H, Murakami K, Kakinoki K, Endo T, Akashi M (1998a) Polymer drugs and polymeric drugs IX: Synthesis and 5-fluorouracil release profiles of biodegradable polymeric prodrugs γ-poly(α-hydroxymethyl-5-fluorouracil-glutamate). J Bioact Compat Polym 13:222–233
Kishida A, Murakami K, Goto H, Kubota H, Endo T, Akashi M (1998b) Polymer drugs and polymeric drugs X: Slow release of 5-fluorouracil from biodegradable poly(γ-glutamic acid) and its benzyl ester matrixes. J Bioact Compat Polym 13:270–278
Kubler-Kielb J, Liu TY, Mocca C, Majadly F, Robbins JB, Schneerson R (2006) Additional conjugation methods and immunogenicity of Bacillus anthracis poly-γ-D-glutamic acid-protein conjugates. Infect Immun 74:4744–4749
Kubota H, Matsunobu T, Uotani K, Takebe H, Satoh A, Tanaka T, Taniguchi M (1993) Production of poly(γ-glutamic acid) by Bacillus subtilis F-2-01. Biosci Biotech Biochem 57:1212–1213
Kunath K, Kopeckova P, Minko T, Kopecek J (2000) HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line. Eur J Pharm Biopharm 49:11–15
Kurosaki T, Kitahara T, Fumoto S, Nishida K, Nakamura J, Niidome T, Kodama Y, Nakagawa H, To H, Sasaki H (2009) Ternary complexes of pDNA, polyethylenimine, and γ-polyglutamic acid for gene delivery systems. Biomaterials 30:2846–2853
Laner R, Vacanti JP (1993) Tissue engineering. Science 260:920–926
Lee KY, Mooney DJ (2001) Hydrogel for tissue engineering. Chem Rev 101:1869–1879
Lee ES, Shin HJ, Na K, Bae YH (2003) Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release 90:363–374
Lee J, Cho EC, Cho K (2004) Incorporation and release behavior of hydrophobic drug in functionalized poly(D, L-lactide)-block-poly(ethylene oxide) micelles. J Control Release 94:323–335
Lee PW, Peng SF, Su CJ, Mi FL, Chen HL, Wei MC, Lin HJ, Sung HW (2008) The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials 29:742–751
Lee TY, Kim YH, Yoon SW, Choi JC, Yang JM, Kim CJ, Schiller JT, Sung MH, Poo HR (2009) Oral administration of poly-γ-glutamate induces TLR4- and dendritic cell-dependent antitumor effect. Cancer Immunol Immunother 58:1781–1794
Leonard CD, Scribner BH (1969) Subdural hematoma in patients undergoing hemodialysis. Lancet 2:239–249
Letchford K, Burt H (2007) A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 65:259–269
Li C (2002) Poly(L-glutamic acid)–anticancer drug conjugates. Adv Drug Deliv Rev 54:695–713
Li SD, Huang L (2006) Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 13:1313–1319
Li C, Wallace S (2008) Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Delivery Rev 60:886–898
Li C, Yu DF, Newman RA, Cabral F, Stephens LC, Hunter N, Milas L, Wallace S (1998) Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res 58:2404–2409
Li C, Newman RA, Wu QP, Ke S, Chen W, Hutto T, Kan Z, Brannan MD, Charnsangavej C, Wallace S (2000) Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor. Cancer Chemother Pharmacol 46:416–422
Liang HF, Yang TF, Huang CT, Chen MC, Sung HW (2005) Preparation of nanoparticles composed of poly(γ-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells. J Control Release 105:213–225
Liang HF, Chen SC, Chen MC, Lee PW, Chen CT, Sung HW (2006a) Paclitaxel-loaded poly(γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells. Bioconjugate Chem 17:291–299
Liang HF, Chen CT, Chen SC, Kulkarni AR, Chiu YL, Chen MC, Sung HW (2006b) Paclitaxel-loaded poly(γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Biomaterials 27:2051–2059
Lin YH, Chung CK, Chen CT, Liang HF, Chen SC, Sung HW (2005) Preparation of nanoparticles composed of chitosan/poly-γ-glutamic acid and evaluation of their permeability through Caco-2 cells. Biomacromolecules 6:1104–1112
Lin J, Zhang S, Chen T, Lin S, Jin H (2007a) Micelle formation and drug release behavior of polypeptide graft copolymer and its mixture with polypeptide block copolymer. Int J Pharm 336:49–57
Lin YH, Mi FL, Chen CT, Chang WC, Peng SF, Liang HF, Sung HW (2007b) Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 8:146–152
Lin YH, Sonaje K, Lin KM, Juang JH, Mi FL, Yang HW, Sung HW (2008) Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J Control Release 132:141–149
Maeda H (2001) SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Delivery Rev 46:169–185
Maeda H, Sawa T, Konno T (2001) Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 74:47–61
Mann A, Richa R, Ganguli M (2008) DNA condensation by poly-L-lysine at the single molecule level: role of DNA concentration and polymer length. J Control Release 125:252–262
Matsuo K, Yoshikawa T, Oda A, Akagi T, Akashi M, Okada N, Nakagawa S (2007) Efficient generation of antigen-specific cellular immunity by vaccination with poly(γ-glutamic acid) nanoparticles entrapping endoplasmic reticulum-targeted peptides. Biochem Biophys Res Commun 362:1069–1072
Matsusaki M, Akashi M (2005) Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(γ-glutamic acid)sulfonate matrix for tissue engineering. Biomacromolecules 6:3351–3356
Matsusaki M, Serizawa T, Kishida A, Endo T, Akashi M (2002) Novel functional biodegradable polymer: Synthesis and anticoagulant activity of poly(γ-glutamic acid)sulfonate (γ-PGA-sulfonate). Bioconjugate Chem 13:23–28
Matsusaki M, Hiwatari K, Higashi M, Kaneko T, Akashi M (2004) Stably-dispersed and surface-functional bionanoparticles prepared by self-assembling amphipathic polymers of hydrophilic poly(γ-glutamic acid) bearing hydrophobic amino acids. Chem Lett 33:398–399
Matsusaki M, Serizawa T, Kishida A, Akashi M (2005a) Novel functional biodegradable polymer II: Fibroblast growth factor-2 activities of poly(γ-glutamic acid)sulfonate. Biomacromolecules 6:400–407
Matsusaki M, Serizawa T, Kishida A, Akashi M (2005b) Novel functional biodegradable polymer III: The construction of poly(γ-glutamic acid)sulfonate hydrogel with fibroblast growth factor-2 activity. J Biomed Mater Res 73A:485–491
Matsusaki M, Yoshida H, Akashi M (2007) The construction of 3D-engineered tissues composed of cells and extracellular matrices by hydrogel template approach. Biomaterials 28:2729–2737
Mauzac M, Jozefonvictz J (1984) Anticoagulant activitiy of dextran derivatives. Part I: Synthesis and characterization. Biomaterials 5:301–304
Mi FL, Wu YY, Lin YH, Sonaje K, Ho YC, Chen CT, Juang JH, Sung HW (2008) Oral delivery of peptide drugs using nanoparticles self-assembled by poly(γ-glutamic acid) and a chitosan derivative functionalized by trimethylation. Bioconjugate Chem 19:1248–1255
Minko T, Kopeckova P, Kopecek J (2000) Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int J Cancer 86:108–117
Morillo M, Martinez de Ilarduya A, Munoz-Guerra S (2001) Comblike alkyl esters of biosynthetic poly(γ-glutamic acid). 1. Synthesis and characterization. Macromolecules 34:7868–7875
Muller M, Reihs T, Ouyang W (2005) Needlelike and spherical polyelectrolyte complex nanoparticles of poly(L-lysine) and copolymers of maleic acid. Langmuir 21:465–469
Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM (2008) Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives. J Control Release 125:193–209
Muzzarelli RAA, Tanfani F, Emanuelli M (1984) Sulfated N-(carboxymethyl)chitosans: Novel blood anticoagulants. Carbohydr Res 126:225–231
Na K, Lee KH, Bae YH (2004) pH-sensitivity and pH-dependent interior structural change of self-assembled hydrogel nanoparticles of pullulan acetate/oligo-sulfonamide conjugate. J Control Release 97:513–525
Nam YS, Kang HS, Park JY, Park TG, Han SH, Chang IS (2003) New micelle-like polymer aggregates made from PEI-PLGA diblock copolymers: micellar characteristics and cellular uptake. Biomaterials 24:2053–2059
Nishimura S, Tokura S (1987) Preparation and antithrombogenic activities of heparinoid from 6-O-(carboxymethyl)chitin. Int J Biol Macromol 9:225–232
Nixon DF, Hioe C, Chen PD, Bian Z, Kuebler P, Li ML, Qiu H, Li XM, Singh M, Richardson J, McGee P, Zamb T, Koff W, Wang CY, O'Hagan D (1996) Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine 14:1523–1530
Obst M, Steinbuchel A (2004) Microbial degradation of poly(amino acid)s. Biomacromolecules 5:1166–1176
Okamoto S, Yoshii H, Akagi T, Akashi M, Ishikawa T, Okuno Y, Takahashi M, Yamanishi K, Mori Y (2007) Influenza hemagglutinin vaccine with poly(γ-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Vaccine 25:8270–8278
Okamoto S, Yoshii H, Ishikawa T, Akagi T, Akashi M, Takahashi M, Yamanishi K, Mori Y (2008) Single dose of inactivated Japanese encephalitis vaccine with poly(γ-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus. Vaccine 26:589–594
Okamoto S, Matsuura M, Akagi T, Akashi M, Tanimoto T, Ishikawa T, Takahashi M, Yamanishi K, Mori Y (2009) Poly(γ-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine 27:5896–5905
Oppermann FB, Fickaitz S, Steinbiichel A (1998) Biodegradation of polyamides. Polym Degrad Stab 59:337–344
Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329–347
Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V (2003) Polymer degradation and in vitro release of a model protein from poly(D, L-lactide-co-glycolide) nano- and microparticles. J Control Release 92:173–187
Peng SF, Yang MJ, Su CJ, Chen HL, Lee PW, Wei MC, Sung HW (2009) Effects of incorporation of poly(γ-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency. Biomaterials 30:1797–1808
Pinzani V, Bressolle F, Haug IJ, Galtier M, Blayac JP, Balmes P (1994) Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemother Pharmacol 35:1–9
Portilla-Arias JA, Camargo B, Garcia-Alvarez M, Martinez de Ilarduya A, Munoz-Guerra S (2009) Nanoparticles made of microbial poly(γ-glutamate)s for encapsulation and delivery of drugs and proteins. J Biomater Sci Polym Ed 20:1065–1079
Prodhomme EJ, Tutt AL, Glennie MJ, Bugg TD (2003) Multivalent conjugates of poly-γ-D-glutamic acid from Bacillus licheniformis with antibody F(ab′) and glycopeptide ligands. Bioconjugate Chem 14:1148–1155
Quellec P, Gref R, Perrin L, Dellacherie E, Sommer F, Verbavatz JM, Alonso MJ (1998) Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. J Biomed Mater Res 42:45–54
Radu JEF, Novak L, Hartmann JF, Beheshti N, Kjoniksen AL, Nystrom B, Borbely J (2008) Structural and dynamical characterization of poly-γ-glutamic acid-based cross-linked nanoparticles. Colloid Polym Sci 286:365–376
Reihs T, Muller M, Lunkwitz K (2004) Preparation and adsorption of refined polyelectrolyte complex nanoparticles. J Colloid Interface Sci 271:69–79
Rhie GE, Roehrl MH, Mourez M, Collier RJ, Mekalanos JJ, Wang JY (2003) A dually active anthrax vaccine that confers protection against both bacilli and toxins. Proc Natl Acad Sci USA 100:10925–10930
Ringsdorf H (1975) Structure and properties of pharmacologically active polymers. J Polym Sci Symp 51:135–153
Sah H (1999) Stabilization of proteins against methylene chloride / water interface induced denaturation and aggregation. J Control Release 58:143–151
Sakuma S, Suzuki N, Kikuchi H, Hiwatari K, Arikawa K, Kishida A, Akashi M (1997) Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches. Int J Pharm 149:93–106
Sakuma S, Hayashi M, Akashi M (2001) Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv Drug Deliv Rev 47:21–37
Sakuma S, Sagawa T, Masaoka Y, Kataoka M, Yamashita S, Shirasaka Y, Tamai I, Ikumi Y, Kida T, Akashi M (2009) Stabilization of enzyme-susceptible glucoside bonds of phloridzin through conjugation with poly(γ-glutamic acid). J Control Release 133:125–131
Sanda F, Fujiyama T, Endo T (2001) Chemical synthesis of poly-γ-glutamic acid by polycondensation of γ-glutamic acid dimer: synthesis and reaction of poly-γ-glutamic acid methyl ester. J Polym Sci A Polym Chem 39:732–741
Sanda F, Fujiyama T, Endo T (2002) Stepwise synthesis of γ-glutamic acid 16-mer. Macromol Chem Phys 203:727–734
Satchi-Fainaro R, Duncan R, Barnes CM (2000) Polymer therapeutics for cancer: current status and future challenges. Adv Polym Sci 193:1–65
Schneerson R, Kubler-Kielb J, Liu TY, Dai ZD, Leppla SH, Yergey A, Backlund P, Shiloach J, Majadly F, Robbins JB (2003) Poly(γ-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine. Proc Natl Acad Sci USA 100:8945–8950
Shih IL, Van YT (2001) The production of poly(γ-glutamic acid) from microorganisms and its various application. Bioresource Technol 79:207–225
Shimokuri T, Kaneko T, Serizawa T, Akashi M (2004) Preparation and thermosensitivity of naturally occurring polypeptide poly(γ-glutamic acid) derivatives modified by alkyl groups. Macromol Biosci 4:407–411
Sonaje K, Lin YH, Juang JH, Wey SP, Chen CT, Sung HW (2009) In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30:2329–2339
Sutherland MD, Kozel TR (2009) Macrophage uptake, intracellular localization, and degradation of poly-γ-D-glutamic acid, the capsular antigen of Bacillus anthracis. Infect Immun 77:532–538
Sutherland MD, Thorkildson P, Parks SD, Kozel TR (2008) In vivo fate and distribution of poly-γ-D-glutamic acid, the capsular antigen from bacillus anthracis. Infect Immun 76:899–906
Suzuki K, Yumura T, Tanaka Y, Serizawa T, Akashi M (2000) Interpenetrating inorganic-organic hybrid gels: Preparation of hybrid and replica gels. Chem Lett 29:1380–1381
Tachibana Y, Kurisawa M, Uyama H, Kobayashi S (2003) Thermo- and pH-responsive biodegradable poly(α-N-substituted γ-glutamine)s. Biomacromolecules 4:1132–1134
Torchilin VP (2006) Multifunctional nanocarriers. Adv Drug Delivery Rev 58:1532–1555
Tsujihara K, Hongu M, Saito K, Inamasu M, Arakawa K, Oku A, Matsumoto M (1996) Na+-glucose cotransporter inhibitors as antidiabetics. I. synthesis and pharmacological properties of 4’-dehydroxyphlorizin derivatives based on a new concept. Chem Pharm Bull 44:1174–1180
Uto T, Wang X, Sato K, Haraguchi M, Akagi T, Akashi M, Baba M (2007) Targeting of antigen to dendritic cells with poly(γ-glutamic acid) nanoparticles induce antigen-specific humoral and cellular immunity. J Immunol 178:2979–2986
Uto T, Akagi T, Hamasaki T, Akashi M, Baba M (2009a) Modulation of innate and adaptive immunity by biodegradable nanoparticles. Immunol Lett 125:46–52
Uto T, Wang X, Akagi T, Zenkyu R, Akashi M, Baba M (2009b) Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles. Biochem Biophys Res Commun 379:600–604
Vasir JK, Labhasetwar V (2007) Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Delivry Rev 59:718–728
Wang TT, Fellows PF, Leighton TJ, Lucas AH (2004) Induction of opsonic antibodies to the γ-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate. FEMS Immunol Med Microbiol 40:231–237
Wang X, Akagi T, Akashi M, Baba M (2007a) Development of core-corona type polymeric nanoparticles as an anti-HIV-1 vaccine. Mini-Rev Org Chem 4:281–290
Wang X, Uto T, Akagi T, Akashi M, Baba M (2007b) Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120. J Virol 81:10009–10016
Wang X, Uto T, Akagi T, Akashi M, Baba M (2008) Poly(γ-glutamic Acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an anti-AIDS vaccine. J Med Virol 80:11–19
Weber J (1990) Poly(γ-glutamic acid)s are the major constituents of nematocysts in Hydra (Hydrozoa, Cnidaria). J Biol Chem 265:9664–9669
Ye H, Jin L, Hu R, Yi Z, Li J, Wu Y, Xi X, Wu Z (2006) Poly(γ, L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice. Biomaterials 27:5958–5965
Yoshida H, Klinkhammer K, Matsusaki M, Moller M, Klee D, Akashi M (2009a) Disulfide-crosslinked electrospun poly(γ-glutamic acid) nonwovens as reduction-responsive scaffolds. Macromol Biosci 9:568–574
Yoshida H, Matsusaki M, Akashi M (2009b) Scaffold-mediated 2D cellular orientations for construction of three dimensionally engineered tissues composed of oriented cells and extracellular matrices. Adv Funct Mater 19:1001–1007
Yoshida H, Matsusaki M, Akashi M (2010) Development of thick and highly cell-incorporated engineered tissues by hydrogel template approach with basic fibroblast growth factor or ascorbic acid. J Biomater Sci Polymer Ed 21:415–428
Yoshikawa T, Okada N, Oda A, Matsuo K, Matsuo MY, Yoshioka Y, Akagi T, Akashi M, Nakagawa S (2008a) Development of amphiphilic γ-PGA-nanoparticle based tumor vaccine: Potential of the nanoparticulate cytosolic protein delivery carrier. Biochem Biophys Res Commun 366:408–413
Yoshikawa T, Okada N, Oda A, Matsuo K, Matsuo K, Kayamuro H, Ishii Y, Yoshinaga T, Akagi T, Akashi M, Nakagawa S (2008b) Nanoparticles built by self-assembly of am phiphilic poly(γ-glutamic acid) can deliver antigens to antigen-presenting cells with high efficiency: A new tumor-vaccine carrier for eliciting effector T cells. Vaccine 26:1303–1313
Zhang L, Eisenberg A (1995) Multiple morphologies of crew-cut aggregates of polystyrene-b-poly(acrylic acid) block copolymers. Science 1268:1728–1731
Zou Y, Wu QP, Tansey W, Chow D, Hung MC, Charnsangavej C, Wallace S, Li C (2001) Effectiveness of water soluble poly(L-glutamic acid)–camptothecin conjugate against resistant human lung cancer xenografted in nude mice. Int J Oncol 18:331–336
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Akagi, T., Matsusaki, M., Akashi, M. (2010). Pharmaceutical and Medical Applications of Poly-Gamma-Glutamic Acid. In: Hamano, Y. (eds) Amino-Acid Homopolymers Occurring in Nature. Microbiology Monographs, vol 15. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12453-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-12453-2_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12452-5
Online ISBN: 978-3-642-12453-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)